scispace - formally typeset
K

Karin Kovar

Researcher at Zurich University of Applied Sciences/ZHAW

Publications -  24
Citations -  1456

Karin Kovar is an academic researcher from Zurich University of Applied Sciences/ZHAW. The author has contributed to research in topics: Pichia pastoris & Trypsinogen. The author has an hindex of 13, co-authored 23 publications receiving 1216 citations. Previous affiliations of Karin Kovar include Zürcher Fachhochschule & Keck Graduate Institute of Applied Life Sciences.

Papers
More filters
Journal ArticleDOI

Promoter library designed for fine-tuned gene expression in Pichia pastoris.

TL;DR: The new PAOX1 synthetic promoter library constitutes a basic toolbox to fine-tune gene expression in metabolic engineering and sequential induction of protein expression in synthetic biology.
Journal ArticleDOI

Best practices in heterotrophic high-cell-density microalgal processes: achievements, potential and possible limitations

TL;DR: It is confirmed that, although fundamental knowledge is now available, the development of efficient, economically feasible large-scale bioprocesses remains an obstacle to the commercialisation of this promising technology.
Journal ArticleDOI

Cultivation strategies to enhance productivity of Pichia pastoris: A review

TL;DR: This review focuses on particular aspects of recombinant protein production related to variations in biomass growth and their implications for strain design and screening, as well as on the concept of rational comparisons between cultivation systems for the development of specific production processes in bioreactors.
Journal ArticleDOI

Flow cytometry for the development of biotechnological processes with microalgae.

TL;DR: The use of flow cytometric (FCM) methods for the analysis of microalgae has been explored in this paper, where the authors present the options for implementation of FCM in the development of biotechnological processes detailed in this review are (i) analyzing the chemical composition of biomass, (ii) monitoring cellular enzyme activity and cell viability, and (iii) sorting cells to isolate those overproducing the target compound or for the preparation of axenic cultures.
Journal ArticleDOI

Implementing CRISPR-Cas technologies in conventional and non-conventional yeasts: Current state and future prospects.

TL;DR: The comparison of innovative CRISPR-Cas expression strategies in yeasts presented here may also serve as guideline to implement and refine CRISpr-Cas systems for highly efficient genome editing in other eukaryotic organisms.